Immunome shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Immunome (IMNM) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Immunome
Tip: Access up to 7 years of quarterly data
All positions including Immunome held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Immunome by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $2.4M | 209k | 11.71 |
| 2025-03-31 | $1.3M | 193k | 6.73 |
| 2024-12-31 | $2.9M | 274k | 10.62 |
| 2024-09-30 | $8.3M | 569k | 14.62 |
| 2024-06-30 | $2.2M | 184k | 12.10 |
| 2024-03-31 | $8.2M | 332k | 24.68 |